Logo

ArcticZymes Inks Enzyme Supply Agreement with GE Healthcare Life Sciences

Jul 12, 2013
Premium

ArcticZymes said last week that it has inked a supply agreement with GE Healthcare Life Sciences for products based on ArcticZymes' portfolio of heat-labile enzymes.

Tromsø, Norway-based ArcticZymes' heat-labile enzyme portfolio includes shrimp alkaline phosphatase, Cod-UNG, DNases and other nucleases, and kits for PCR decontamination and genomic DNA removal. The cold-adapted enzymes are particularly well-suited for molecular biology research and diagnostic applications, ArcticZymes said.

ArcticZymes, a subsidiary of Biotec Pharmacon, has previously inked similar supply agreements with New England Biolabs and Affymetrix.

Financial terms of the agreement were not disclosed.

Filed under

PCR
Business News
GE Healthcare
ArcticZymes
supply agreement
Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.